← Human Trials & Peer-Reviewed Studies
A high-fat diet raises fasting plasma CCK but does not affect upper gut motility, PYY, and ghrelin, or energy intake during CCK-8 infusion in lean men
Plain-language guide to PMID 18003795 (2008): single-blind randomized controlled trial of Ghrelin and Cholecystokinin (CCK).
Key Facts
- PMID
- 18003795
- Journal
- American journal of physiology. Regulatory, integrative and comparative physiology
- Year
- 2008
- Study type
- Randomized Controlled Trial
- Authors
- Little TJ et al. (7 authors)
- DOI
- 10.1152/ajpregu.00597.2007
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Ghrelin and Cholecystokinin (CCK).
There is evidence from studies in animals that the effects of both fat and CCK on gastrointestinal function and energy intake are attenuated by consumption of a high-fat diet.
In humans, the effects of exogenous CCK-8 on antropyloroduodenal motility, plasma CCK, peptide YY (PYY), and ghrelin concentrations, appetite, and energy intake are attenuated by a high-fat diet.
Who Took Part
The age groups tagged for this paper are teenagers and adults, men only.
How the Study Was Run
In design terms this was a randomized, single-blind and crossover study.
Random assignment meant chance, not the researchers, decided who got Ghrelin and who got the comparison, which limits bias.
Only one side, usually the participants, was kept unaware of whether Ghrelin was given.
In the crossover set-up each of the participants took both Ghrelin and the comparison in turn, acting as their own control.
What Was Measured
There is evidence from studies in animals that the effects of both fat and CCK on gastrointestinal function and energy intake are attenuated by consumption of a high-fat diet.
PubMed files the paper under topics including Cholecystokinin, Dietary Fats, Duodenum, Energy Intake, Fasting, Gastrointestinal Motility and Ghrelin.
What This Means in Plain Language
The paper is a randomized, single-blind and crossover study of Ghrelin and Cholecystokinin (CCK).
The publication is from 2008 (American journal of physiology. Regulatory, integrative and comparative physiology), a journal based in United States.
More context: the Ghrelin compound page and the Cholecystokinin (CCK) compound page, all human trials.
Our Notes on the Compounds
Ghrelin: A 28-amino-acid stomach hormone that signals hunger and triggers growth hormone release; studied in human trials as an infusion.
Cholecystokinin (CCK): A gut and brain peptide hormone that stimulates gallbladder contraction and signals fullness.
Sincalide: A synthetic 8-amino-acid fragment of cholecystokinin (Kinevac) used in gallbladder and pancreas imaging.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.